Insider Transactions in Q2 2023 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2023
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,780
-6.18%
|
$860,640
$88.93 P/Share
|
|
May 23
2023
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+13.19%
|
-
|
|
May 23
2023
|
Elaine J Heron Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+4.35%
|
-
|
|
May 23
2023
|
Maykin Ho Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+20.12%
|
-
|
|
May 23
2023
|
Robert J. Hombach Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+12.08%
|
-
|
|
May 23
2023
|
V Bryan Lawlis Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+11.22%
|
-
|
|
May 23
2023
|
Richard A Meier Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+3.5%
|
-
|
|
May 23
2023
|
David E I Pyott Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+8.51%
|
-
|
|
May 23
2023
|
Dennis Slamon Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+11.97%
|
-
|
|
May 23
2023
|
Mark J Alles Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+21.73%
|
-
|
|
May 23
2023
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,190
+15.36%
|
-
|
|
May 16
2023
|
Erin Burkhart GVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
796
-5.35%
|
$73,232
$92.02 P/Share
|
|
May 16
2023
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
210
-0.26%
|
-
|
|
May 12
2023
|
Elaine J Heron Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,137
-6.52%
|
$570,741
$93.93 P/Share
|
|
May 12
2023
|
Elaine J Heron Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+8.29%
|
$569,500
$67.81 P/Share
|
|
May 12
2023
|
Richard A Meier Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,137
-5.22%
|
$570,741
$93.93 P/Share
|
|
May 12
2023
|
Richard A Meier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+6.75%
|
$569,500
$67.81 P/Share
|
|
May 12
2023
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
39,981
-4.28%
|
$3,718,233
$93.93 P/Share
|
|
May 12
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,500
+4.65%
|
$3,115,500
$67.81 P/Share
|
|
May 11
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
30,000
-3.32%
|
$2,820,000
$94.89 P/Share
|
|
May 11
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.17%
|
$2,010,000
$67.81 P/Share
|
|
May 10
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
30,000
-3.33%
|
$2,820,000
$94.99 P/Share
|
|
May 10
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.17%
|
$2,010,000
$67.81 P/Share
|
|
May 09
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
30,000
-2.23%
|
$2,850,000
$95.2 P/Share
|
|
May 09
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.17%
|
$2,010,000
$67.81 P/Share
|
|
May 04
2023
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,302
-8.66%
|
$408,690
$95.45 P/Share
|
|
Apr 28
2023
|
Henry J Fuchs President, Worldwide R&D |
BUY
Grant, award, or other acquisition
|
Direct |
317
+0.18%
|
$20,922
$66.88 P/Share
|
|
Apr 28
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
318
+0.48%
|
$20,988
$66.88 P/Share
|
|
Apr 28
2023
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
317
+0.39%
|
$20,922
$66.88 P/Share
|
|
Apr 28
2023
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+0.07%
|
$20,922
$66.88 P/Share
|
|
Apr 28
2023
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239
+0.48%
|
$15,774
$66.88 P/Share
|
|
Apr 10
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.29%
|
$990,000
$99.56 P/Share
|
|
Apr 10
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.24%
|
$670,000
$67.81 P/Share
|
|
Apr 06
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.29%
|
$960,000
$96.13 P/Share
|
|
Apr 06
2023
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.24%
|
$670,000
$67.81 P/Share
|
|
Apr 03
2023
|
V Bryan Lawlis Director |
SELL
Open market or private sale
|
Direct |
8,500
-22.7%
|
$824,500
$97.09 P/Share
|
|
Apr 03
2023
|
V Bryan Lawlis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+18.5%
|
$569,500
$67.81 P/Share
|